Angios is a newly founded biotech company, located in Innsbruck, Austria. Our research strives to develop new treatments for (diabetic) vascular diseases. Angios aims to develop new treatments by pursuing preidentified targets for diabetic retinopathy and to build a unique platform to use blood vessels for regenerative purposes.
Speculative application
Speculative application

Currently, we do not have any particular job offers available. If you're interested in working with us, we gladly receive your CV and letter of motivation for future consideration. We also accept applications from Master students who want to pursue their thesis with us.

Please contact

Get in touch